Guggenheim Capital LLC Xencor Inc Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Xencor Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 10,218 shares of XNCR stock, worth $211,206. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,218

Previous 20,571 50.33%

Holding current value

$211,206

Previous $389,000 47.3%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$15.7 - $21.65 $162,542 - $224,142	-10,353 Reduced 50.33%	10,218 $205,000
Q2 2024 Aug 14, 2024	BUY	$18.21 - $24.5 $374,597 - $503,989	20,571 New	20,571 $389,000
Q3 2023 Nov 14, 2023	SELL	$20.08 - $25.39 $158,491 - $200,403	-7,893 Reduced 37.59%	13,102 $264,000
Q2 2023 Aug 11, 2023	SELL	$24.77 - $29.9 $118,524 - $143,071	-4,785 Reduced 18.56%	20,995 $524,000
Q1 2023 May 10, 2023	BUY	$25.95 - $36.95 $111,325 - $158,515	4,290 Added 19.96%	25,780 $719,000
Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $58,380 - $72,675	2,355 Added 12.31%	21,490 $559,000
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $57,561 - $75,844	-2,338 Reduced 10.89%	19,135 $497,000
Q2 2022 Aug 15, 2022	BUY	$19.74 - $29.01 $75,189 - $110,499	3,809 Added 21.56%	21,473 $588,000
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $63,818 - $99,578	2,392 Added 15.66%	17,664 $471,000
Q4 2021 Feb 14, 2022	BUY	$33.67 - $43.44 $123,972 - $159,946	3,682 Added 31.77%	15,272 $613,000
Q3 2021 Nov 15, 2021	BUY	$30.65 - $35.68 $121,741 - $141,720	3,972 Added 52.14%	11,590 $378,000
Q2 2021 Aug 13, 2021	SELL	$34.33 - $44.68 $16,066 - $20,910	-468 Reduced 5.79%	7,618 $263,000
Q1 2021 May 13, 2021	SELL	$40.81 - $53.88 $249,226 - $329,045	-6,107 Reduced 43.03%	8,086 $348,000
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $519,889 - $676,012	14,193 New	14,193 $619,000
Q3 2018 Nov 14, 2018	SELL	$35.69 - $47.65 $260,394 - $347,654	-7,296 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$28.41 - $42.41 $10,994 - $16,412	-387 Reduced 5.04%	7,296 $270,000
Q1 2018 May 15, 2018	BUY	$21.18 - $33.78 $162,725 - $259,531	7,683 New	7,683 $231,000

Others Institutions Holding XNCR

# of Institutions

216

Shares Held

71.5M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.23B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Xencor Inc Transaction History